Researchers used stem-cell derived organoids from Crohn’s disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.
Researchers used stem-cell derived organoids from Crohn’s disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.